Genus plc (GENSF)
Genus plc operates in the Biotechnology industry of the Healthcare sector, headquartered in Basingstoke, HM, GB. The stock last traded at $31.07, up 0.00% on the session, giving a market capitalisation of $2.06B. On trailing twelve-month figures it carries a trailing P/E of 31.33, a net margin of 7.1%. Its beta of 0.90 implies it has historically moved less than the broad market.
Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development. Through its PIC brand, the company supplies breeding pigs and boar semen, enabling the production of swine with specific traits for pork processing. Furthermore, under the ABS, Genus, and Bovec labels, it provides bull semen and bovine embryos to facilitate the breeding of calves with targeted characteristics for dairy and beef output. Genus plc also extends specialized technical support to agricultural producers. Established in 1994, the company's headquarters are located in Basingstoke, United Kingdom.
Genus plc is most often compared with the following Healthcare names: